You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 14, April 8, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening for Cystic Fibrosis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—Each year, an estimated 1000 individuals are born with cystic fibrosis (CF) in the United States; average lifetime costs are at least $800000. Prenatal screening for CF has been studied in several pilot programs in Europe and the United States.1-5 A National Institutes of Health (NIH) expert review panel recently issued recommendations about genetic testing for CF and concluded that such testing should be offered, but should be limited to couples either planning pregnancy or seeking prenatal testing.6 It identified a variety of racial and ethnic groups as being eligible for such testing and called for research into "the cost-effective approaches to treatment and screening in different settings."6 This recommendation deserves consideration, because 2 features of CF (birth prevalence and frequency of specific mutations) differ widely among racial groups.

Table 1 demonstrates the extent to which these differences influence the cost-effectiveness of prenatal screening for CF. In . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Report Card on Molecular Genetic Testing: Room for Improvement?
Grody and Pyeritz
JAMA 1999;281:845-847.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.